Charles River Laboratories International (CRL) Change in Accured Expenses (2009 - 2025)

Charles River Laboratories International's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$2.6 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses rose 90.0% year-over-year to -$2.6 million; the TTM figure through Dec 2025 stood at $79.3 million (up 387.31% YoY), while the FY2025 annual figure was $79.3 million, up 387.31% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at -$2.6 million, down from $42.9 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $51.3 million in Q2 2021, with the low at -$79.8 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is $4.9 million (2021), against an average of $3.3 million.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses jumped 563.47% in 2023, then tumbled 188.33% in 2024.
• Charles River Laboratories International's Change in Accured Expenses stood at $26.1 million in 2021, then plunged by 136.14% to -$9.4 million in 2022, then sank by 69.58% to -$16.0 million in 2023, then tumbled by 60.23% to -$25.6 million in 2024, then jumped by 90.0% to -$2.6 million in 2025.
• Business Quant data shows CRL's Change in Accured Expenses at -$2.6 million in Q4 2025, $42.9 million in Q3 2025, and $23.7 million in Q2 2025.